Русский
Mucoactive drugs in the treatment of respiratory diseases in children
DOI: https://dx.doi.org/10.18565/pharmateca.2023.1-2.32-37
M.D. Shakhnazarova, N.A. Geppe, I.V. Ozerskaya, I.V. Grebeneva, N.G. Kolosova, S.I. Shatalina, E.V. Frolkova, O.V. Batyreva, S.E. Fidanyan
Department of Children’s Diseases, Clinical Institute of Children’s Health n.a. N.F. Filatov, Sechenov University, Moscow, Russia
The formation of mucus in the airways is the first line of defense against microbial agents, allergens, and foreign particles. However, excessive sputum production and difficulty in clearing the airways can lead to many respiratory diseases. Mucoactive substances are drugs that either change the properties of sputum or reduce its production. The article provides a brief overview of common mucoactive agents, as well as current data on the main therapeutic effects of ambroxol.
About the Autors
Corresponding author: Marina D. Shakhnazarova, Cand. Sci. (Med.), Associate Professor at the Department of Children’s Diseases, Clinical Institute of Children’s Health n.a. N.F. Filatov, Sechenov University, Moscow, Russia; marinashakh@mail.ru
Similar Articles
